NASDAQ:VIVE
Viveve Medical, Inc.
- Stock
Last Close
0.00
24/09 20:00
Market Cap
3.22K
Beta: 0.24
Volume Today
430
Avg: 48.38K
PE Ratio
0.00
PFCF: 0.00
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 149.50K - | 124K 17.06% | 840K 577.42% | 2.12M 152.14% | 2.54M 19.85% | 3.25M 28.21% | 4.49M 37.96% | 4.06M 9.63% | 2.36M 41.76% | |
average payables | 401K - | 420.50K 4.86% | 924K 119.74% | 2.26M 144.48% | 3.94M 74.52% | 4.40M 11.52% | 2.80M 36.29% | 1.24M 55.57% | 1.18M 5.14% | |
average receivables | 452K - | 254K 43.81% | 299.50K 17.91% | 1.34M 348.08% | 4.15M 209.39% | 5.96M 43.51% | 3.64M 38.94% | 1.17M 67.80% | 659.50K 43.70% | |
book value per share | -42.58K - | -373.45 99.12% | 783.75 309.87% | -43.92 105.60% | -148.61 238.38% | 158.15 206.42% | 132.40 16.28% | 4.43 96.65% | 1.49 66.31% | |
capex per share | -51.95 - | -21.70 58.22% | -27.76 27.90% | -51.73 86.34% | -68.97 33.33% | -8.71 87.37% | -0.50 94.30% | -0.05 90.89% | ||
capex to depreciation | -2.09 - | -1.42 32.25% | -2.31 62.92% | -2.02 12.61% | -2.73 35.21% | -0.92 66.25% | -0.60 34.52% | -0.40 33.51% | ||
capex to operating cash flow | 0.02 - | 0.01 54.23% | 0.01 58.35% | 0.03 83.46% | 0.05 91.44% | 0.03 29.99% | 0.05 47.32% | 0.04 30.93% | ||
capex to revenue | -1.30 - | -0.08 94.21% | -0.04 52.41% | -0.06 65.13% | -0.12 95.41% | -0.17 43.09% | -0.14 13.88% | -0.07 50.22% | ||
cash per share | 4.93K - | 397.42 91.94% | 1.47K 268.76% | 876.82 40.17% | 1.18K 35.13% | 950.55 19.77% | 106.65 88.78% | 4.15 96.11% | 1.90 54.19% | |
days of inventory on hand | 80.42 - | 956.30 1,089.08% | 573.99 39.98% | 212.65 62.95% | 111.21 47.70% | 134.27 20.73% | 319.63 138.05% | 229.15 28.31% | 92.54 59.62% | |
days payables outstanding | 292.14 - | 3.04K 939.51% | 530.64 82.53% | 244.23 53.97% | 223.31 8.57% | 130.20 41.70% | 105.73 18.79% | 62.04 41.32% | 93.04 49.97% | |
days sales outstanding | 143.82 - | 24.33 83.08% | 149.58 514.72% | 106.88 28.55% | 148.33 38.79% | 112.44 24.20% | 87.43 22.24% | 51.30 41.33% | 31.18 39.21% | |
debt to assets | 2.91K - | 1.09 99.96% | 0.42 61.35% | 0.66 57.40% | 0.80 21.23% | 0.65 18.76% | 0.16 75.83% | 0.35 123.66% | 0.21 41.43% | |
debt to equity | -683.76 - | -2.97 99.57% | 1.23 141.31% | -23.78 2,036.26% | -11.13 53.17% | 6.21 155.82% | 0.26 95.86% | 0.84 226.61% | 0.36 57.75% | |
dividend yield | 0.00 - | 0.24 - | 0.41 - | |||||||
earnings yield | 0.78 - | -0.76 197.88% | -0.37 51.98% | -0.42 15.69% | -0.42 0.52% | -1.51 258.00% | -29.71 1,870.31% | -2.87 90.34% | -1.98 30.91% | |
enterprise value | 8.26M - | 9.71M 17.57% | 31.42M 223.53% | 49.04M 56.06% | 95.17M 94.09% | 33.62M 64.68% | -7.48M 122.26% | 6.73M 189.96% | -2.31M 134.32% | |
enterprise value over ebitda | -1.78 - | -1.75 1.60% | -2.62 49.95% | -2.62 0.04% | -2.83 7.82% | -0.75 73.55% | 0.26 134.62% | -0.36 238.49% | 0.11 131.27% | |
ev to operating cash flow | -1.72 - | -1.62 5.72% | -2.58 58.94% | -2.71 5.22% | -2.73 0.72% | -0.78 71.43% | 0.24 130.71% | -0.44 284.46% | 0.18 140.59% | |
ev to sales | 6.48 - | 107.91 1,564.26% | 21.72 79.88% | 6.87 68.38% | 6.23 9.34% | 1.82 70.84% | -1.14 162.78% | 1.23 207.83% | -0.36 129.26% | |
free cash flow per share | -30.79K - | -2.71K 91.19% | -2.45K 9.67% | -1.99K 18.82% | -2.04K 2.75% | -1.46K 28.74% | -259.03 82.21% | -10.18 96.07% | -1.32 87.02% | |
free cash flow yield | -1.07 - | -0.75 29.54% | -0.36 51.89% | -0.39 6.57% | -0.41 6.47% | -1.39 237.28% | -20.56 1,382.22% | -2.17 89.47% | -1.16 46.47% | |
graham net net | -44.85K - | -965.36 97.85% | 203.36 121.07% | -429.00 310.96% | -691.26 61.13% | -195.16 71.77% | 51.79 126.54% | -0.59 101.14% | 0.94 258.94% | |
graham number | 146.58K - | 4.80K 96.72% | 6.61K 37.56% | 1.47K 77.78% | 2.65K 80.24% | 2.37K 10.28% | 1.06K 55.51% | 36.69 96.53% | 8.72 76.24% | |
income quality | -1.37 - | 0.97 170.61% | 0.98 1.24% | 0.90 8.36% | 0.94 4.85% | 0.86 8.58% | 0.73 14.80% | 0.70 5.36% | 0.58 15.90% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -13.96 - | -9.99 28.46% | -28.89 189.32% | -13.65 52.75% | -10.64 22.04% | -10.28 3.37% | -6.88 33.15% | -20.32 195.59% | -21.55 6.05% | |
interest debt per share | 29.11M - | 1.36K 100.00% | 1.05K 23.27% | 1.19K 14.13% | 1.84K 53.91% | 1.12K 38.79% | 68.96 93.86% | 4.30 93.76% | 0.63 85.38% | |
inventory turnover | 4.54 - | 0.38 91.59% | 0.64 66.60% | 1.72 169.92% | 3.28 91.21% | 2.72 17.17% | 1.14 57.99% | 1.59 39.48% | 3.94 147.63% | |
invested capital | -683.76 - | -2.97 99.57% | 1.23 141.31% | -23.78 2,036.26% | -11.13 53.17% | 6.21 155.82% | 0.26 95.86% | 0.84 226.61% | 0.36 57.75% | |
market cap | 4.49M - | 8.11M 80.45% | 33.95M 318.75% | 47.49M 39.90% | 86.96M 83.09% | 32.61M 62.50% | 1.57M 95.18% | 7.40M 370.37% | 11.50M 55.53% | |
net current asset value | -6.68M - | -1.18M 82.28% | 3.56M 400.59% | -1.02M 128.77% | -6.61M 545.02% | -18K 99.73% | 11.73M 65,283.33% | 3.19M 72.84% | 11.39M 257.42% | |
net debt to ebitda | -0.81 - | -0.29 64.35% | 0.21 172.97% | -0.08 139.14% | -0.24 195.86% | -0.02 90.84% | 0.31 1,501.38% | 0.04 88.75% | 0.67 1,801.05% | |
net income per share | 22.43K - | -2.74K 112.23% | -2.47K 9.84% | -2.18K 11.86% | -2.09K 4.00% | -1.58K 24.37% | -374.40 76.36% | -13.50 96.39% | -2.26 83.24% | |
operating cash flow per share | -30.79K - | -2.66K 91.36% | -2.43K 8.72% | -1.96K 19.23% | -1.99K 1.57% | -1.39K 30.36% | -250.32 81.96% | -9.68 96.13% | -1.28 86.82% | |
payables turnover | 1.25 - | 0.12 90.38% | 0.69 472.29% | 1.49 117.27% | 1.63 9.37% | 2.80 71.52% | 3.45 23.14% | 5.88 70.42% | 3.92 33.32% | |
receivables turnover | 2.54 - | 15 491.05% | 2.44 83.73% | 3.42 39.96% | 2.46 27.95% | 3.25 31.93% | 4.17 28.60% | 7.12 70.44% | 11.70 64.50% | |
research and ddevelopement to revenue | 1.66 - | 15.84 853.06% | 3.45 78.24% | 1.17 66.02% | 0.81 31.08% | 0.74 8.25% | 1.31 76.59% | 0.94 28.49% | 1.50 60.79% | |
return on tangible assets | 2.25 - | -2.69 219.75% | -1.08 59.80% | -1.38 27.86% | -1.02 26.55% | -1.05 3.43% | -1.73 64.91% | -1.28 26.25% | -0.88 31.03% | |
revenue per share | 8.17K - | 39.96 99.51% | 288.13 620.97% | 774.34 168.75% | 873.80 12.84% | 596.19 31.77% | 52.63 91.17% | 3.48 93.38% | 0.64 81.71% | |
roe | -0.53 - | 7.35 1,494.91% | -3.16 142.96% | 49.66 1,672.90% | 14.09 71.63% | -10.01 171.07% | -2.83 71.76% | -3.05 7.69% | -1.51 50.26% | |
roic | -0.00 - | -3.75 400,278.15% | -1.40 62.58% | -2.15 53.41% | -1.27 41.12% | -1.27 0.29% | -1.59 25.41% | -1.41 11.32% | -1.09 22.19% | |
sales general and administrative to revenue | ||||||||||
shareholders equity per share | -42.58K - | -373.45 99.12% | 783.75 309.87% | -43.92 105.60% | -148.61 238.38% | 158.15 206.42% | 132.40 16.28% | 4.43 96.65% | 1.49 66.31% | |
stock based compensation to revenue | 0.16 - | 2.04 1,195.83% | 0.15 92.56% | 0.14 9.64% | 0.12 10.87% | 0.16 33.85% | 0.37 122.97% | 0.48 32.39% | 0.59 21.54% | |
tangible asset value | -6.64M - | -841K 87.34% | 3.94M 568.01% | -405K 110.29% | -2.60M 541.98% | 4.91M 288.92% | 16.52M 236.34% | 6.97M 57.79% | 15.07M 116.03% | |
tangible book value per share | -42.58K - | -373.45 99.12% | 783.75 309.87% | -43.92 105.60% | -148.61 238.38% | 158.15 206.42% | 132.40 16.28% | 4.43 96.65% | 1.49 66.31% | |
working capital | 534K - | -1.18M 321.72% | 3.56M 400.59% | 6.79M 90.81% | 22.67M 233.82% | 31.14M 37.38% | 15.88M 49.00% | 8.63M 45.68% | 17.70M 105.20% |
All numbers in USD (except ratios and percentages)